Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.56 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27347353 | 0.83 | ALDH1A1 (0.74) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL29623278 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL354679 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL5358823 | 0.82 | ALDH1A1 (0.71) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| Water SCHEMBL29724498 | 0.80 | ALDH1A1 (0.96) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL29540343 | 0.80 | ALDH1A1 (0.69) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7808078 | 0.80 | ALDH1A1 (0.96) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL219544 | 0.80 | ALDH1A1 (0.69) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL28888127 | 0.80 | ALDH1A1 (0.96) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL1756873 | 0.80 | ALDH1A1 (0.69) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-7344656-B2 | Storing a composition in an alcoholic gel | TRUOX, INC. (US) | 2008-03-18 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| WO-2005013913-A2 | PEROXYGEN CONTAINING PARTICLE IN AN ALCOHOL CONTAINING GEL | MATERIALS TECHNOLOGY LABORATORIES, INC. (US) | 2005-02-17 | — | — | WO | claimed |
| US-20050032660-A1 | Storing a composition in an alcoholic gel | TRUOX, INC. | 2005-02-10 | — | — | US | claimed |
| WO-1999023294-A1 | PROCESSES OF BLEACHING FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1999023197-A1 | PROCESSES OF SOAKING FABRICS WITH A LIQUID AQUEOUS PERSULFATE SALT-CONTAINING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1999023196-A1 | LIQUID AQUEOUS BLEACHING COMPOSITIONS PACKAGED IN A UV RESISTANT CONTAINER | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1999023195-A1 | MULTI-PURPOSE LIQUID AQUEOUS BLEACHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-14 | — | — | WO | claimed |
| EP-0915150-A1 | Processes of soaking fabrics with a liquid aqueous persulfate salt-containing composition | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-12 | — | — | EP | claimed |
| EP-0913463-A1 | Multi-purpose liquid aqueous bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| EP-0913462-A1 | Liquid aqueous bleaching compositions packaged in a UV-resistant container | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| EP-0913515-A1 | Process of bleaching fabrics | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| WO-2025215303-A1 | SULFONAMIDES, COMPOSITIONS COMPRISING SAID SULFONAMIDES, METHODS FOR THE PREPARATION OF SAID SULFONAMIDES, AND SAID SULFONAMIDES FOR USE AS MEDICAMENT AND IN A METHOD FOR THE TREATMENT OR PREVENTION OF AN OCULAR DISEASE OR CONDITION, OR IDIOPATHIC INTRACRANIAL HYPERTENSION | ITÄ-SUOMEN YLIOPISTO (FI) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025215286-A1 | SULFONAMIDES, COMPOSITIONS COMPRISING SAID SULFONAMIDES, METHODS FOR THE PREPARATION OF SAID SULFONAMIDES, AND SAID SULFONAMIDES FOR USE AS MEDICAMENT AND IN A METHOD FOR THE TREATMENT OR PREVENTION OF AN OCULAR DISEASE OR CONDITION, OR IDIOPATHIC INTRACRANIAL HYPERTENSION | ITÄ-SUOMEN YLIOPISTO (FI) | 2025-10-16 | — | — | WO | disclosed |
| US-20250236792-A1 | ETCHANT COMPOSITION FOR ETCHING SILICON AND METHOD OF FORMING PATTERN USING THE SAME | DONGWOO FINE-CHEM CO., LTD. (KR) | 2025-07-24 | — | — | US | disclosed |
| US-4373101-A | BACTERICIDES; ANIMAL GROWTH REGULATORS; LOW TOXICITY; ANIMAL HUSBANDRY | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1983-02-08 | — | — | US | disclosed |
| US-4373101-A | BACTERICIDES; ANIMAL GROWTH REGULATORS; LOW TOXICITY; ANIMAL HUSBANDRY | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1983-02-08 | — | — | US | disclosed |
| US-4006092-A | PEROXY COMPOUND, ALDEHYDE OR KETONE, VINYL POLYMER, BUFFER | THE PROCTER & GAMBLE COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
| US-4005029-A | Laundering adjunct | THE PROCTER & GAMBLE COMPANY (US) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | ALDH1A1 330/4885HPGD 1094/4885ALOX15 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.